RESUMEN
Objective To explore the value of virtual touch tissue quantification(VTQ) in diagnosis of mucoepidermoid carcinoma (MECa) of parotid gland.Methods The sonographic and VTQ findings of 36 patients with MECa of parotid gland proved by pathology were analyzed retrospectively.The patients were divided into 3 groups according to pathology.50 normal subjects were choesn as control group.Results There were significant differences of shear wave velocity (SWV) between MECa groups and control group as well as among MECa groups (all P ＜0.01).Conclusions VTQ provides quantitative information about tissue stiffness which is useful for the diagnosis of MECa of parotid gland.
RESUMEN
BACKGROUND:Studies have shown that bone morphogenetic proteins play a key role in skeletal development. Platelet-rich plasma alone in animal or clinical trials cannot significantly promote bone graft healing. OBJECTIVE:To investigate the osteogenesis effect of bone morphogenetic protein-4 compounded with platelet-rich plasma the bone defect area. METHODTwenty-four New Zealand white rabbits were selected to establish maxil ary bone defect models, and then were randomly divided into four groups, six rats in each group. Group A was blank control group;Group B wasβ-tricalcium phosphate (0.1 g)+Bio-gide group;group C wasβ-tricalcium phosphate (0.1 g)+Bio-gide+platelet-rich plasma (1 mL) group;and group D wasβ-tricalcium phosphate (0.1 g)+Bio-gide+platelet-rich plasma (1 mL)+bone morphogenetic protein-4 (5μg). Gross observation, histological observation and imaging analysis were performed for analysis of new bone formation at weeks 4, 8, 12 after modeling. RESULTS AND CONCLUSION:After 4 weeks, group D had more new bone and vessels formed in the bone defect area than the group B (P<0.01);however, the amount of new bone was higher in the group B than the group A (P<0.01). After 4, 8, 12 weeks, the amount of new bone in the bone defect area was higher in the group D than the groups B and C (P<0.01), and lowest in the group A (P<0.01). In theβ-tricalcium phosphate scaffold, platelet-rich plasma combined with bone morphogenetic protein can significantly promote the healing of bone defects.